Betty Y.S. Kim

机构：The University of Texas MD Anderson Cancer Center · ORCID：0000-0001-6890-8355

发表论文 268 篇 · 总被引 15259 次 · h-index 51

代表论文

• SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade (2025 · Nature · 被引 108)
• Nanotechnology for immuno-oncology (2025 · Nature Cancer · 被引 28)
• Engineered exosomes for targeted microRNA delivery to reverse liver fibrosis (2025 · Biomaterials · 被引 24)
• In Situ Programming of the Tumor Microenvironment to Alleviate Immunosuppression for Pancreatic Cancer Immunotherapy (2025 · Advanced Science · 被引 13)
• Engineering challenges and translational opportunities in emerging gene delivery platforms (2026 · Nature Biomedical Engineering · 被引 11)
• Targeting immune checkpoint LAIR1 with antibody blockade or 3-in-1 CAR T cells enhances antitumor response (2025 · Journal of Clinical Investigation · 被引 8)